Merrimack Pharmaceuticals Inc (MACK)
14.73
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
14.74
0.00 (0.00%)
After-Hours: 20:00
Merrimack Pharmaceuticals Max Drawdown (5Y): 97.30% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 97.30% |
February 29, 2024 | 97.30% |
January 31, 2024 | 97.30% |
December 31, 2023 | 97.30% |
November 30, 2023 | 97.30% |
October 31, 2023 | 97.30% |
September 30, 2023 | 97.30% |
August 31, 2023 | 97.30% |
July 31, 2023 | 97.30% |
June 30, 2023 | 97.30% |
May 31, 2023 | 97.30% |
April 30, 2023 | 97.30% |
March 31, 2023 | 97.30% |
February 28, 2023 | 97.30% |
January 31, 2023 | 97.30% |
December 31, 2022 | 97.30% |
November 30, 2022 | 97.30% |
October 31, 2022 | 97.30% |
September 30, 2022 | 97.30% |
August 31, 2022 | 97.30% |
July 31, 2022 | 97.30% |
June 30, 2022 | 97.30% |
May 31, 2022 | 97.30% |
April 30, 2022 | 97.30% |
March 31, 2022 | 97.30% |
Date | Value |
---|---|
February 28, 2022 | 97.30% |
January 31, 2022 | 97.30% |
December 31, 2021 | 97.30% |
November 30, 2021 | 97.30% |
October 31, 2021 | 97.30% |
September 30, 2021 | 97.30% |
August 31, 2021 | 97.30% |
July 31, 2021 | 97.30% |
June 30, 2021 | 97.30% |
May 31, 2021 | 97.30% |
April 30, 2021 | 97.30% |
March 31, 2021 | 97.30% |
February 28, 2021 | 97.30% |
January 31, 2021 | 97.30% |
December 31, 2020 | 97.30% |
November 30, 2020 | 97.30% |
October 31, 2020 | 97.30% |
September 30, 2020 | 97.30% |
August 31, 2020 | 97.30% |
July 31, 2020 | 97.30% |
June 30, 2020 | 97.30% |
May 31, 2020 | 97.30% |
April 30, 2020 | 97.30% |
March 31, 2020 | 97.30% |
February 29, 2020 | 96.03% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.03%
Minimum
Apr 2019
97.30%
Maximum
Mar 2020
97.07%
Average
97.30%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.90% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 4.330 |
Beta (5Y) | 1.426 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 120.6% |
Historical Sharpe Ratio (5Y) | 0.1903 |
Historical Sortino (5Y) | 0.8326 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.14% |